Fosun Pharma announces up to HK$1 billion H-share repurchase plan
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. said it intends to repurchase its H-shares with an aggregate amount of up to HK$1 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.